Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study

被引:3
|
作者
Kuusimaki, Tomi [1 ,2 ]
Sainio, Jani [3 ,4 ]
Kurki, Samu [3 ,4 ]
Vahlberg, Tero [5 ]
Kaasinen, Valtteri [1 ,2 ]
机构
[1] Univ Turku, Clin Neurosci, Turku, Finland
[2] Turku Univ Hosp, Neuroctr, Hameentie 11,POB 52, FIN-20521 Turku, Finland
[3] Univ Turku, Auria Biobank, Turku, Finland
[4] Turku Univ Hosp, Turku, Finland
[5] Univ Turku, Dept Biostat, Turku, Finland
关键词
Parkinson 's disease; Prodromal; Data mining; Electronical health records; Mortality; Prognosis; MOTOR; RISK; ASSOCIATION; DEPRESSION; SURVIVAL; FEATURES; CRITERIA;
D O I
10.1016/j.parkreldis.2021.12.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The relationship of prodromal markers of PD with PD mortality is unclear. Electronic health records (EHRs) provide a large source of raw data that could be useful in the identification of novel relevant prognostic factors in PD. We aimed to provide a proof of concept for automated data mining and pattern recognition of EHRs of PD patients and to study associations between prodromal markers and PD mortality. Methods: Data from EHRs of PD patients (n = 2522) were collected from the Turku University Hospital database between 2006 and 2016. The data contained >27 million words/numbers and >750000 unique expressions. The 5000 most common words were identified in three-year time period before PD diagnosis. Cox regression was used to investigate the association of expressions with the 5-year survival of PD patients. Results: During the five-year period after PD diagnosis, 839 patients died (33.3%). If expressions associated with psychosis/hallucinations were identified within 3 years before the diagnosis, worse survival was observed (hazard ratio = 1.71, 95%CI = 1.46-1.99, p < 0.001). Similar effects were observed for words associated with cognition (1.23, 1.05-1.43, p = 0.009), constipation (1.34, 1.15-1.56, p = 0.0002) and pain (1.34, 1.12-1.60, p = 0.001). Conclusions: Automated mining of EHRs can predict relevant clinical outcomes in PD. The approach can identify factors that have previously been associated with survival and detect novel associations, as observed in the link between poor survival and prediagnostic pain. The significance of early pain in PD prognosis should be the focus of future studies with alternate methods.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [31] Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol
    Dissanayaka, Nadeeka
    Pourzinal, Dana
    Byrne, Gerard J.
    Yang, Jihyun
    Mcmahon, Katie L.
    Pontone, Gregory M.
    O'Sullivan, John D.
    Adam, Robert
    Littleford, Roberta
    Chatfield, Mark
    Lehn, Alexander
    Mari, Zoltan
    Bakker, Arnold
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [32] Famotidine, a Histamine H-2 Receptor Antagonist, Does Not Reduce Levodopa-Induced Dyskinesia in Parkinson's Disease: A Proof-of-Concept Study
    Mestre, Tiago A.
    Shah, Binit B.
    Connolly, Barbara S.
    de Aquino, Camila
    Al Dhakeel, Amaal
    Walsh, Richard
    Ghate, Taneera
    Lui, Jane P.
    Fox, Susan H.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (03): : 219 - 224
  • [33] Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study
    Kamath, Megan
    Shekhtman, Grigoriy
    Grogan, Tristan
    Hickey, Michelle J.
    Silacheva, Irina
    Shah, Karishma S.
    Shah, Kishan S.
    Hairapetian, Adrian
    Gonzalez, Diego
    Godoy, Giovanny
    Reed, Elaine F.
    Elashoff, David
    Bondar, Galyna
    Deng, Mario C.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Levetiracetam for the treatment of mild cognitive impairment in Parkinson’s disease: a double-blind controlled proof-of-concept trial protocol
    Nadeeka Dissanayaka
    Dana Pourzinal
    Gerard J. Byrne
    Jihyun Yang
    Katie L. McMahon
    Gregory M. Pontone
    John D. O’Sullivan
    Robert Adam
    Roberta Littleford
    Mark Chatfield
    Alexander Lehn
    Zoltan Mari
    Arnold Bakker
    Pilot and Feasibility Studies, 9
  • [35] Mortality and causes of death in patients with Parkinson's disease: a nationwide population-based cohort study
    Ryu, Dong-Woo
    Han, Kyungdo
    Cho, A-Hyun
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [36] Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study
    Habedank, Dirk
    Schefold, Joerg C.
    Bernhardt, Carolin
    Karhausen, Tim
    Doehner, Wolfram
    Anker, Stefan D.
    Reinke, Petra
    CardioRenal Medicine, 2017, 7 (01) : 50 - 59
  • [37] Webcam-Based Eye-Tracking of Attentional Biases in Alzheimer's Disease: A Proof-Of-Concept Study
    Greenaway, Anne-Marie
    Hwang, Faustina
    Nasuto, Slawomir
    Ho, Aileen
    CLINICAL GERONTOLOGIST, 2024, 47 (01) : 98 - 109
  • [38] Harnessing electronic health records to study emerging environmental disasters: a proof of concept with perfluoroalkyl substances (PFAS)
    Boland, Mary Regina
    Davidson, Lena M.
    Canelon, Silvia P.
    Meeker, Jessica
    Penning, Trevor
    Holmes, John H.
    Moore, Jason H.
    NPJ DIGITAL MEDICINE, 2021, 4 (01)
  • [39] Mortality in Parkinson's Disease: A 38-Year Follow-up Study
    Pinter, Bernadette
    Diem-Zangerl, Anja
    Wenning, Gregor Karl
    Scherfler, Christoph
    Oberaigner, Willi
    Seppi, Klaus
    Poewe, Werner
    MOVEMENT DISORDERS, 2015, 30 (02) : 266 - 269
  • [40] Machine learning models in the prediction of 1-year mortality in patients with advanced hepatocellular cancer on immunotherapy: a proof-of-concept study
    Lui, Thomas Ka Luen
    Cheung, Ka Shing
    Leung, Wai Keung
    HEPATOLOGY INTERNATIONAL, 2022, 16 (04) : 879 - 891